Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment - PubMed (original) (raw)
Comparative Study
doi: 10.1017/S1461145705005651. Epub 2005 Jun 21.
Affiliations
- PMID: 15967059
- DOI: 10.1017/S1461145705005651
Free article
Comparative Study
Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment
Matthew N Hill et al. Int J Neuropsychopharmacol. 2006 Jun.
Free article
Abstract
This study examined the effects of long-term cannabinoid administration on the responsivity of 5-HT1A and 5-HT2A receptors, which have been implicated in depression. Animals received 12 d administration of the potent cannabinoid receptor agonist HU-210 (100 microg/kg), following which they were monitored on their behavioural, physiological and hormonal responses to a single challenge of a 5-HT1A and 5-HT2A receptor agonist, 8-OH-DPAT (0.3 mg/kg) and DOI (1 mg/kg) respectively. Chronic HU-210 treatment lead to a significant enhancement of DOI-induced wet-dog shakes, but a reduction of DOI-induced back muscle contractions. DOI-induced corticosterone release was unaffected by HU-210 treatment. The hyperthermic response to DOI appeared to be potentiated by long-term HU-210 treatment, as 50% of these subjects died from an apparent serotonin syndrome with core temperatures exceeding 43 degrees C. The 8-OH-DPAT-induced hypothermic response and elevation of corticosterone were both significantly attenuated by long- term HU-210 treatment. These data imply that chronic cannabinoid treatment may up-regulate 5-HT2A receptor activity while concurrently down-regulating 5-HT1A receptor activity, a finding similar to that sometimes observed in depression. This may partially explain the association between excessive cannabis consumption and the induction of affective disease.
Similar articles
- 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.
de Bortoli VC, Yamashita PS, Zangrossi H Jr. de Bortoli VC, et al. J Psychopharmacol. 2013 Dec;27(12):1116-23. doi: 10.1177/0269881113492900. Epub 2013 Jun 20. J Psychopharmacol. 2013. PMID: 23787365 - Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
Zhang Y, Gray TS, D'Souza DN, Carrasco GA, Damjanoska KJ, Dudas B, Garcia F, Zainelli GM, Sullivan Hanley NR, Battaglia G, Muma NA, Van de Kar LD. Zhang Y, et al. J Pharmacol Exp Ther. 2004 Jul;310(1):59-66. doi: 10.1124/jpet.103.062224. Epub 2004 Apr 2. J Pharmacol Exp Ther. 2004. PMID: 15064330 - Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
Limón-Morales O, Soria-Fregozo C, Arteaga-Silva M, Vázquez-Palacios G, Bonilla-Jaime H. Limón-Morales O, et al. Physiol Behav. 2014 Jan 30;124:37-44. doi: 10.1016/j.physbeh.2013.10.026. Epub 2013 Nov 6. Physiol Behav. 2014. PMID: 24211235 - Thermogenesis in brown adipose tissue: increase by 5-HT2A receptor activation and decrease by 5-HT1A receptor activation in conscious rats.
Ootsuka Y, Blessing WW. Ootsuka Y, et al. Neurosci Lett. 2006 Mar 6;395(2):170-4. doi: 10.1016/j.neulet.2005.10.062. Epub 2005 Nov 15. Neurosci Lett. 2006. PMID: 16293365 - Prevention of Photocarcinogenesis by Agonists of 5-HT1A and Antagonists of 5-HT2A Receptors.
Menezes AC, Raposo S, Simões S, Ribeiro H, Oliveira H, Ascenso A. Menezes AC, et al. Mol Neurobiol. 2016 Mar;53(2):1145-1164. doi: 10.1007/s12035-014-9068-z. Epub 2015 Jan 15. Mol Neurobiol. 2016. PMID: 25589005 Review.
Cited by
- Role of endocannabinoid signaling in anxiety and depression.
Patel S, Hillard CJ. Patel S, et al. Curr Top Behav Neurosci. 2009;1:347-71. doi: 10.1007/978-3-540-88955-7_14. Curr Top Behav Neurosci. 2009. PMID: 21104391 Free PMC article. - Emotion regulation deficits in regular marijuana users.
Zimmermann K, Walz C, Derckx RT, Kendrick KM, Weber B, Dore B, Ochsner KN, Hurlemann R, Becker B. Zimmermann K, et al. Hum Brain Mapp. 2017 Aug;38(8):4270-4279. doi: 10.1002/hbm.23671. Epub 2017 May 31. Hum Brain Mapp. 2017. PMID: 28560818 Free PMC article. - Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice.
Mosaffa S, Ahmadi H, Khakpai F, Ebrahimi-Ghiri M, Zarrindast MR. Mosaffa S, et al. Psychopharmacology (Berl). 2021 Jan;238(1):259-269. doi: 10.1007/s00213-020-05679-6. Epub 2020 Nov 14. Psychopharmacology (Berl). 2021. PMID: 33190164 Free PMC article. - Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.
Franklin JM, Mathew M, Carrasco GA. Franklin JM, et al. Neurosci Lett. 2013 Aug 26;548:165-9. doi: 10.1016/j.neulet.2013.05.039. Epub 2013 May 27. Neurosci Lett. 2013. PMID: 23721787 Free PMC article. - Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts.
Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Allebeck P. Manrique-Garcia E, et al. BMC Psychiatry. 2012 Aug 16;12:112. doi: 10.1186/1471-244X-12-112. BMC Psychiatry. 2012. PMID: 22897939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources